<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154763</url>
  </required_header>
  <id_info>
    <org_study_id>717602410</org_study_id>
    <nct_id>NCT02154763</nct_id>
  </id_info>
  <brief_title>The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery</brief_title>
  <acronym>INOPAIN</acronym>
  <official_title>A Pilot Study to Assess the Feasibility of a Future Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Role of Intra-Peritoneal Ropivacaine in Gastric Bypass Surgery: INOPAIN Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study in a randomized, controlled, double-blinded format and will evaluate
      the ability of a local anesthetic, Ropivacaine, to decrease pain after gastric bypass
      surgery. The drug will be administered into the abdomen during a bariatric bypass surgery.
      After surgery, patients who received Ropivacaine will be compared to those without
      Ropivacaine to determine its effect on reducing pain, recovery of lung function, ability to
      walk, and quality of life during recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Postoperative pain control remains a major challenge for surgical procedures,
      including laparoscopic gastric bypass. Pain management is particularly relevant in obese
      patients who experience a higher number of of cardiovascular and pulmonary events. effective
      pain management may reduce their risk of serious postoperative complications, such as deep
      venous thrombosis and pulmonary emboli. The objective of this study is to evaluate the
      efficacy of intraperitoneal local anaesthetic, ropivacaine, to reduce postoperative pain in
      patients undergoing laparoscopic Roux-en-Y gastric bypass.

      Methods and Analysis: A randomized controlled trial will be conducted to compare
      intraperitoneal ropivacaine (Intervention) versus normal saline (placebo) in 120 adult
      patients undergoing bariatric surgery. Ropivacaine will be infused over the oesophageal
      hiatus and throughout the abdomen. Patients in the control arm will undergo the same
      treatment as normal saline. The primary end point will be postoperative pain at 1, 2 and 4
      hours postoperatively. Pain measurements will then occur every 4 hours for 24 h and every 8h
      until discharge. Secondary endpoints will include opioid use, peak expiratory flow, 6 min
      walk distance and quality of life. Intention-to-treat analysis will be used and repeated
      measures will be analysed using mixed model approach. post-hoc pairwise comparison of the
      treatment groups at different time points will be carried out using multiple comparisons with
      adjustments to the type 1 error. Results of the study will inform the feasibility of
      effectiveness of intraperitoneal ropivacaine.

      Ethics and dissemination This study has been approved by the Ottawa Health Science Network
      Research Ethics Board and Health Canada in April 2014. The findings of the study will be
      disseminated through national and international conferences and peer-reviewed journals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>0-1 h Postoperative Pain Level</measure>
    <time_frame>0-1 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1-2 h Postoperative Pain Level</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>2-4 Hours Post Operative Pain Level</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>4-8 Hours Post Operative Pain Level</measure>
    <time_frame>4-8 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>8-12 Hours Post Operative Pain Level</measure>
    <time_frame>8-12 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12-16 Hours Post Operative Pain Level</measure>
    <time_frame>12-16 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>16-20 Hours Post Operative Pain Level</measure>
    <time_frame>16-20 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>20-24 Hours Post Operative Pain Level</measure>
    <time_frame>20-24 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24-32 Hours Post Operative Pain Level</measure>
    <time_frame>24-32 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>32-40 Hours Post Operative Pain Level</measure>
    <time_frame>32-40 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>40-48 Hours Post Operative Pain Level</measure>
    <time_frame>40-48 hours post operatively</time_frame>
    <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>1 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>2 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>4 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>8h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>8 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>12 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>16h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>16 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>20h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>20 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>24 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>32h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>32 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>40h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>40 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>48h Peak Expiratory Flow (PEF) Score</measure>
    <time_frame>48 hours post operatively</time_frame>
    <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walking Distance Post Operative Day 1 (POD1)</measure>
    <time_frame>Post operative day 1</time_frame>
    <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walking Distance Post Operative Day 2 (POD2)</measure>
    <time_frame>Post operative day 2</time_frame>
    <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Day 1 Quality of Recovery Questionnaire (QR-40)</measure>
    <time_frame>Post operative day 1</time_frame>
    <description>40-item questionnaire provides a global score(Minimum-score 40, Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1, maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions, subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>0-1 h Postoperative Tylenol Consumption</measure>
    <time_frame>0-1 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>0-1 h Postoperative Ketorolac Consumption</measure>
    <time_frame>0-1 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>0-1 h Postoperative Dilaudid Consumption</measure>
    <time_frame>0-1 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>0-1 h Postoperative Tramadol Consumption</measure>
    <time_frame>0-1 h Postoperative Tramadol consumption</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>0-1 h Postoperative Fentanyl Consumption</measure>
    <time_frame>0-1 hours post operatively</time_frame>
    <description>The amount in mcg of Fentanyl administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-2 h Postoperative Tylenol Consumption</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-2 h Postoperative Ketorolac Consumption</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-2 h Postoperative Dilaudid Consumption</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-2 h Postoperative Tramadol Consumption</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-2 h Postoperative Fentanyl Consumption</measure>
    <time_frame>1-2 hours post operatively</time_frame>
    <description>The amount in mcg of Fentanyl administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-4 h Postoperative Tylenol Consumption</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-4 h Postoperative Ketorolac Consumption</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-4 h Postoperative Dilaudid Consumption</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-4 h Postoperative Tramadol Consumption</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-4 h Postoperative Fentanyl Consumption</measure>
    <time_frame>2-4 hours post operatively</time_frame>
    <description>The amount in mcg of Fentanyl administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-12 h Postoperative Tylenol Consumption</measure>
    <time_frame>4-12 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-12 h Postoperative Ketorolac Consumption</measure>
    <time_frame>4-12 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-12 h Postoperative Tramadol Consumption</measure>
    <time_frame>4-12 hours post operatively</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-12 h Postoperative Dilaudid Consumption</measure>
    <time_frame>4-12 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-24 h Postoperative Tylenol Consumption</measure>
    <time_frame>12-24 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-24 h Postoperative Ketorolac Consumption</measure>
    <time_frame>12-24 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-24 h Postoperative Tramadol Consumption</measure>
    <time_frame>12-24 hours post operatively</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-24 h Postoperative Dilaudid Consumption</measure>
    <time_frame>12-24 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-48 h Postoperative Tylenol Consumption</measure>
    <time_frame>24-48 hours post operatively</time_frame>
    <description>The amount in mg of Tylenol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-48 h Postoperative Ketorolac Consumption</measure>
    <time_frame>24-48 hours post operatively</time_frame>
    <description>The amount in mg of Ketorolac administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-48 h Postoperative Tramadol Consumption</measure>
    <time_frame>24-48 hours post operatively</time_frame>
    <description>The amount in mg of Tramadol administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-48 h Postoperative Dilaudid Consumption</measure>
    <time_frame>24-48 hours post operatively</time_frame>
    <description>The amount in mg of Dilaudid administered to patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Day 7-10 Quality of Recovery Questionnaire (QR-40)</measure>
    <time_frame>Post operative day 7-10</time_frame>
    <description>40-item questionnaire provides a global score(Minimum-score 40,Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1,maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions,subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walking Distance Post Operative Day 7-10 (POD 7-10)</measure>
    <time_frame>Post operative day 7-10 (Follow-up Clinic)</time_frame>
    <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Intraperitoneal Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intraperitoneal Normal Saline: 100mL (Milliliter) normal saline administered as in intervention arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraperitoneal ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (Milliliter) (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL (Milliliter) of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Intraperitoneal ropivacaine</arm_group_label>
    <other_name>NAROPINÂ®</other_name>
    <other_name>84057-95-4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <arm_group_label>Intraperitoneal Normal Saline</arm_group_label>
    <other_name>Sodium Chloride</other_name>
    <other_name>7647-14-5</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing Roux-en-Y gastric bypass surgery;

          -  Patients who able to tolerate general anesthetic and pneumoperitoneum;

          -  Patients who able to provide informed consent for the surgery;

          -  Patients over the age of 18 years;

        Exclusion Criteria:

          -  Patient undergoing planned Sleeve Gastrectomy (inta-op conversion to Sleeve
             Gastrectomy after delivery of intraperitoneal ropivacaine will be included and
             analyzed using intention-to-treat approach)

          -  Patients with an allergy to local anesthetics

          -  Patients with severe underlying cardiovascular disease (ie: congestive heart failure,
             conduction abnormalities, and ischemic heart disease)

          -  Patients with chronic renal disease Stage 3 or greater (Creatinine clearance less than
             60mL/hr (millilitre per hour))

          -  Patients with hepatic dysfunction Child-Pugh Class B or C

          -  Patients with previous foregut surgery including esophageal, gastric, liver, and
             pancreas resections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Mamazza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ottawa Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 16, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <results_first_submitted>July 13, 2016</results_first_submitted>
  <results_first_submitted_qc>September 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 15, 2019</results_first_posted>
  <last_update_submitted>March 1, 2019</last_update_submitted>
  <last_update_submitted_qc>March 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bariatric surgery</keyword>
  <keyword>Bariatrics</keyword>
  <keyword>Local anesthetic</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Intraperitoneal</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intraperitoneal Normal Saline</title>
          <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
        </group>
        <group group_id="P2">
          <title>Intraperitoneal Ropivacaine</title>
          <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intraperitoneal Normal Saline</title>
          <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
        </group>
        <group group_id="B2">
          <title>Intraperitoneal Ropivacaine</title>
          <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="46"/>
            <count group_id="B3" value="92"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.1" spread="9.44"/>
                    <measurement group_id="B2" value="44.4" spread="9.42"/>
                    <measurement group_id="B3" value="44.75" spread="9.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.82" spread="6.57"/>
                    <measurement group_id="B2" value="48.57" spread="6.07"/>
                    <measurement group_id="B3" value="47.195" spread="6.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Pain Syndromes</title>
          <description>Information collected Preoperatively and data indicates the number of participants who had Pain syndromes.</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Asthma</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Cardiovascular Disease</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Arthritis</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>On Diabetic Medications</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>On Pain Medications</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Caesarean section</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Laparoscopic Cholecystectomy</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior Surgery</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>0-1 h Postoperative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>0-1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9762" spread="2.5191"/>
                    <measurement group_id="O2" value="4.3149" spread="2.1074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>1-2 h Postoperative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5307" spread="1.6086"/>
                    <measurement group_id="O2" value="3.6911" spread="1.522"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-4 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2733" spread="1.3186"/>
                    <measurement group_id="O2" value="3.1978" spread="1.1836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>4-8 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>4-8 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>4-8 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6507" spread="1.7729"/>
                    <measurement group_id="O2" value="3.8387" spread="1.6156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>8-12 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>8-12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>8-12 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7955" spread="2.0667"/>
                    <measurement group_id="O2" value="3.9056" spread="1.6866"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>12-16 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>12-16 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>12-16 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4419" spread="2.2152"/>
                    <measurement group_id="O2" value="3.9444" spread="1.9283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>16-20 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>16-20 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>16-20 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4186" spread="1.899"/>
                    <measurement group_id="O2" value="3.8081" spread="1.6071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>20-24 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>20-24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>20-24 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2386" spread="1.6548"/>
                    <measurement group_id="O2" value="3.4651" spread="1.5976"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>24-32 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>24-32 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>24-32 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2568" spread="1.7858"/>
                    <measurement group_id="O2" value="3.1974" spread="1.9951"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>32-40 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>32-40 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>32-40 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8143" spread="1.7409"/>
                    <measurement group_id="O2" value="2.9955" spread="1.9079"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>40-48 Hours Post Operative Pain Level</title>
        <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
        <time_frame>40-48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>40-48 Hours Post Operative Pain Level</title>
          <description>Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome).</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients being discharged from hospital early or refusing reading; varying the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7661" spread="1.9842"/>
                    <measurement group_id="O2" value="2.9394" spread="1.3507"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>1h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="202.9" spread="99.9948"/>
                    <measurement group_id="O2" value="200.3" spread="88.4809"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>2h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="243" spread="104.1"/>
                    <measurement group_id="O2" value="239.8" spread="84.9128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>4h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>4h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="251.9" spread="93.5798"/>
                    <measurement group_id="O2" value="256.1" spread="77.5092"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>8h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>8 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>8h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="250.9" spread="81.9403"/>
                    <measurement group_id="O2" value="255.3" spread="86.4081"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>12h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>12h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="240" spread="88.7052"/>
                    <measurement group_id="O2" value="241.6" spread="73.7843"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>16h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>16 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>16h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="233.4" spread="86.6212"/>
                    <measurement group_id="O2" value="242.2" spread="76.4464"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>20h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>20 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>20h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246" spread="97.9415"/>
                    <measurement group_id="O2" value="245.1" spread="66.3817"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>24h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="255.2" spread="92.1195"/>
                    <measurement group_id="O2" value="253.8" spread="73.1017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>32h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>32 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>32h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="256.62" spread="95.183"/>
                    <measurement group_id="O2" value="265.5" spread="84.941"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>40h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>40 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>40h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="255.3" spread="96.6315"/>
                    <measurement group_id="O2" value="265.8" spread="81.654"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>48h Peak Expiratory Flow (PEF) Score</title>
        <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
        <time_frame>48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>48h Peak Expiratory Flow (PEF) Score</title>
          <description>Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point.</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="285.3" spread="97.1162"/>
                    <measurement group_id="O2" value="285.3" spread="84.6803"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Minute Walking Distance Post Operative Day 1 (POD1)</title>
        <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
        <time_frame>Post operative day 1</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walking Distance Post Operative Day 1 (POD1)</title>
          <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.
The analysis was done and revised by our Statistician</population>
          <units>Meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="205.8" spread="94.3378"/>
                    <measurement group_id="O2" value="182.4" spread="97.1065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Minute Walking Distance Post Operative Day 2 (POD2)</title>
        <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
        <time_frame>Post operative day 2</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walking Distance Post Operative Day 2 (POD2)</title>
          <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>Meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="260" spread="87.8853"/>
                    <measurement group_id="O2" value="217.2" spread="101.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Day 1 Quality of Recovery Questionnaire (QR-40)</title>
        <description>40-item questionnaire provides a global score(Minimum-score 40, Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1, maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions, subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
        <time_frame>Post operative day 1</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Day 1 Quality of Recovery Questionnaire (QR-40)</title>
          <description>40-item questionnaire provides a global score(Minimum-score 40, Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1, maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions, subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163" spread="16.4944"/>
                    <measurement group_id="O2" value="163.6" spread="14.6931"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>0-1 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to the patient</description>
        <time_frame>0-1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm prior to dissection.</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) prior to dissection.</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to the patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.2222" spread="206.6"/>
                    <measurement group_id="O2" value="49.2391" spread="192.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>0-1 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>0-1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="7.8335"/>
                    <measurement group_id="O2" value="6.413" spread="8.6707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>0-1 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>0-1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1008.9" spread="951.5"/>
                    <measurement group_id="O2" value="925" spread="641.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>0-1 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>0-1 h Postoperative Tramadol consumption</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3333" spread="12.6131"/>
                    <measurement group_id="O2" value="2.1739" spread="10.3092"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>0-1 h Postoperative Fentanyl Consumption</title>
        <description>The amount in mcg of Fentanyl administered to patient</description>
        <time_frame>0-1 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>0-1 h Postoperative Fentanyl Consumption</title>
          <description>The amount in mcg of Fentanyl administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mcg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5556" spread="43.722"/>
                    <measurement group_id="O2" value="42.9348" spread="45.5409"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-2 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to patient</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.2" spread="272.9"/>
                    <measurement group_id="O2" value="141.3" spread="271.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-2 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3333" spread="6.3604"/>
                    <measurement group_id="O2" value="2.3913" spread="5.3478"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-2 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="291.1" spread="488.9"/>
                    <measurement group_id="O2" value="489.1" spread="582.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-2 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4444" spread="19.43"/>
                    <measurement group_id="O2" value="8.6957" spread="19.1612"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-2 h Postoperative Fentanyl Consumption</title>
        <description>The amount in mcg of Fentanyl administered to patient</description>
        <time_frame>1-2 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>1-2 h Postoperative Fentanyl Consumption</title>
          <description>The amount in mcg of Fentanyl administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mcg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="17.9962"/>
                    <measurement group_id="O2" value="7.6087" spread="16.5576"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-4 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to patient</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="216.4" spread="309.6"/>
                    <measurement group_id="O2" value="240.2" spread="317.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-4 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2222" spread="6.9213"/>
                    <measurement group_id="O2" value="1.0087" spread="3.7421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-4 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="415.6" spread="604.5"/>
                    <measurement group_id="O2" value="484.8" spread="707.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-4 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2222" spread="21.7307"/>
                    <measurement group_id="O2" value="15.2174" spread="23.2608"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-4 h Postoperative Fentanyl Consumption</title>
        <description>The amount in mcg of Fentanyl administered to patient</description>
        <time_frame>2-4 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>2-4 h Postoperative Fentanyl Consumption</title>
          <description>The amount in mcg of Fentanyl administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mcg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4444" spread="13.3663"/>
                    <measurement group_id="O2" value="33.1522" spread="191.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>4-12 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to patient</description>
        <time_frame>4-12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>4-12 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1140.9" spread="441.5"/>
                    <measurement group_id="O2" value="1187" spread="394.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>4-12 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>4-12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>4-12 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8889" spread="11.2961"/>
                    <measurement group_id="O2" value="5.2174" spread="9.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>4-12 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>4-12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>4-12 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1111" spread="38.86"/>
                    <measurement group_id="O2" value="85.8696" spread="31.0252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>4-12 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>4-12 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>4-12 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2000" spread="1714.1"/>
                    <measurement group_id="O2" value="1830.4" spread="2018.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>12-24 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to patient</description>
        <time_frame>12-24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>12-24 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1921.1" spread="414.7"/>
                    <measurement group_id="O2" value="1837" spread="460.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>12-24 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>12-24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>12-24 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3333" spread="11.3016"/>
                    <measurement group_id="O2" value="5.5435" spread="10.1778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>12-24 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>12-24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>12-24 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141.1" spread="38.86"/>
                    <measurement group_id="O2" value="138" spread="31.9458"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>12-24 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>12-24 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>12-24 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2066.7" spread="1923.5"/>
                    <measurement group_id="O2" value="2760.9" spread="3085.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24-48 h Postoperative Tylenol Consumption</title>
        <description>The amount in mg of Tylenol administered to patient</description>
        <time_frame>24-48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>24-48 h Postoperative Tylenol Consumption</title>
          <description>The amount in mg of Tylenol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3033.3" spread="1239.5"/>
                    <measurement group_id="O2" value="2826.1" spread="1330.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24-48 h Postoperative Ketorolac Consumption</title>
        <description>The amount in mg of Ketorolac administered to patient</description>
        <time_frame>24-48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>24-48 h Postoperative Ketorolac Consumption</title>
          <description>The amount in mg of Ketorolac administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3333" spread="7.8044"/>
                    <measurement group_id="O2" value="3.2609" spread="8.8955"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24-48 h Postoperative Tramadol Consumption</title>
        <description>The amount in mg of Tramadol administered to patient</description>
        <time_frame>24-48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>24-48 h Postoperative Tramadol Consumption</title>
          <description>The amount in mg of Tramadol administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="216.7" spread="97.1175"/>
                    <measurement group_id="O2" value="215.2" spread="101.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24-48 h Postoperative Dilaudid Consumption</title>
        <description>The amount in mg of Dilaudid administered to patient</description>
        <time_frame>24-48 hours post operatively</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>24-48 h Postoperative Dilaudid Consumption</title>
          <description>The amount in mg of Dilaudid administered to patient</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2933.3" spread="3563.7"/>
                    <measurement group_id="O2" value="3000" spread="3489.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Day 7-10 Quality of Recovery Questionnaire (QR-40)</title>
        <description>40-item questionnaire provides a global score(Minimum-score 40,Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1,maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions,subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
        <time_frame>Post operative day 7-10</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Day 7-10 Quality of Recovery Questionnaire (QR-40)</title>
          <description>40-item questionnaire provides a global score(Minimum-score 40,Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1,maximum score of 5 for each question.unit is scores on a scale for all questions.
Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions,subscore range between 5-25
Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of &quot;None of the time (Poor)&quot;and 5 represents the answer&quot;All of the time (Excellent)&quot;Part B, score of 1 represents the answer&quot;All of the time (Excellent)&quot; and 5 represents&quot;None of the time (Poor)</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Early Discharge or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183.5" spread="14.1829"/>
                    <measurement group_id="O2" value="182.7" spread="14.0707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Minute Walking Distance Post Operative Day 7-10 (POD 7-10)</title>
        <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
        <time_frame>Post operative day 7-10 (Follow-up Clinic)</time_frame>
        <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Missing Appointment or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraperitoneal Normal Saline</title>
            <description>Intraperitoneal Normal Saline: 100mL normal saline administered as in intervention arm
Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Intraperitoneal Ropivacaine</title>
            <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walking Distance Post Operative Day 7-10 (POD 7-10)</title>
          <description>6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome)</description>
          <population>Overall Number of Participants Analyzed is not consistent with numbers provided Participant Flow module due to patients refusing, Missing Appointment or being unable to provide the reading for outcome during the allocated time frame which could vary the number of results obtained in a specific time frame.</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="373.3" spread="68.1203"/>
                    <measurement group_id="O2" value="352.4" spread="90.2276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected up to postoperative day 7</time_frame>
      <desc>Safety end points are:
Serious adverse event (SAE) rates
Surgical complication rates
Anticipated SAEs include the risks of an anaesthetic, bleeding, wound infection, bowel injury, unexpected leak, pneumothorax, obstruction and general complications such as a thromboembolic events, pneumonia, cardiac events and stroke.
Adverse events are collected on regular intervals until postoperative day 7</desc>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Intraperitoneal Saline: 100mL normal saline administered as in intervention arm</description>
        </group>
        <group group_id="E2">
          <title>Intraperitoneal Ropivacaine</title>
          <description>The abdomen will be entered and trocars placed in the usual manner. Using a standard suction/irrigation device and tubing, 200mg of Ropivacaine (0.2% Ropivacaine in 100mL Normal Saline) will be instilled into the abdomen at the start of the case, prior to dissection as follows. Under direct visualization, 50mL (of the 100mL) will be infused over the esophageal hiatus. The remaining 50mL will be infused throughout the abdomen. The infusion line will then be flushed with 30mL of Normal Saline to ensure the entire treatment dose is delivered, and no Ropivacaine remains in the tubing. The remainder of the surgery will proceed as usual.
Ropivacaine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr.Joseph Mamazza</name_or_title>
      <organization>The Ottawa Hospital</organization>
      <phone>613-798-5555</phone>
      <email>jmamazza@toh.on.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

